Sources Consulted Secondary data for the market study was gathered from multiple credible sources, including: Government databases, regulatory bodies, and public institutions International organizations (WHO, OECD, IMF, World Bank, etc.) Commercial and paid databases Industry associations, trade publications, and technical journals Company annual reports, investor presentations, press releases, and SEC filings Academic research papers, patents, and scientific literature Previous market research publications and syndicated reports These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights
Urinary Side Effects Explained Zepbound Zepbound Is Zepbound a Peptide
In the 52-week study of more than 600 adults in China with type 2 diabetes, participants who received ecnoglutide saw their average blood sugar drop by about 1.9 percent, compared to a 1.65 percent drop in participants who received dulaglutide
The molecular basis for the delayed absorption of the once-daily human GLP-1 analogue, liraglutide